Login / Signup

Risk of Relapse After COVID-19 Vaccination Among Patients With Multiple Sclerosis in France: A Self-Controlled Case Series.

Xavier MoissetEmmanuelle LerayChouki ChenafFrederic TaitheBertrand AudoinAurelien MulliezPierre Clavelou
Published in: Neurology (2024)
This study provides Class III evidence that COVID-19 vaccination does not increase the risk of severe relapse in patients with MS.
Keyphrases
  • coronavirus disease
  • sars cov
  • free survival
  • mass spectrometry
  • multiple sclerosis
  • ms ms
  • early onset
  • respiratory syndrome coronavirus